Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: Results of a multicenter study of 73 patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 2, 2004, Pages 267-272

  Poirier, Marie France ^a   Laqueille, Xavier ^a   Jalfre, Valérie ^a   Willard, Dominique ^a   Bourdel, Marie Chantal ^a   Fermanian, Jacques ^a   Olié, Jean Pierre ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Heroin addiction; High dosage buprenorphine; Logistic regression analysis

Indexed keywords

BUPRENORPHINE; OPIATE;

ALCOHOLISM; ANAMNESIS; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEPRESSION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; HEROIN DEPENDENCE; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTICENTER STUDY; NARCOTIC DEPENDENCE; PATIENT SELECTION; PREDICTION; PROBABILITY; RATING SCALE; SCORING SYSTEM; SUBSTITUTION REACTION; TREATMENT WITHDRAWAL; URINALYSIS;

EID: 1642441360     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2003.10.003     Document Type: Article

References (27)

1. APA Diagnostic and Statistical Manual of Mental Disorders - Revised. 3rd ed. 1987;APA, Washington, DC.
2. Bickel W.K., Stizer M.L., Bigelow G.E., Liebson I.A., Jasinski D.R., Johnson R.E. Buprenorphine: dose related blockade of opioid challenge effects in opioid dependent humans. J. Pharmacol. Exp. Ther. 247:1988;47-53.
3. Bodkin J.A., Zornberg G.L., Lukas S.E., Cole J.O. Buprenorphine treatment of refractory depression. J. Clin. Psychopharmacol. 15:1995;49-57.
4. Cacciola J.S., Alterman A.I., Rutherford M.J., Snider E.C. Treatment response of antisocial substance abusers. J. Nerv. Ment. Dis. 183:1995;166-171.
5. Gasquet I., Lançon C., Parquet P. Facteurs prédictifs de réponse au traitement substitutif par buprénorphine haut dosage. Etude naturaliste en médecine générale. L'Encephale. XXV:1999;641-645.
6. Guy W. ECDEU Assessment Manual for Psychopharmacology. 2nd ed. revised:1976;National Institute of Mental Health, Rockville, MD. 500 pp.
7. Jasinski D.R., Pevnick J.S., Griffith J.D. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen. Psychiatry. 35:1978;501-516.
8. Johnson R.E., Jaffe J.H., Fudala P.J. A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 267:1992;2750-2753.
9. Jouvent R., Vindreau C., Montreuil M., Bungener C., Widlöcher D. La clinique polydimensionnelle de l'humeur dépressive. Nouvelle version de l'échelle EHD. Psychiatr. Psychobiol. 3:1988;245-253.
10. Kosten T.R., Rounsaville B.J., Kleber H.D. A 2.5 year follow-up of cocaine use among treated opioid addicts: have our treatment helped? Arch. Gen. Psychiatry. 4:1987;281-284.
11. Kosten T.R., Kleber H.D., Morgan C. Treatment of cocaine abuse with buprenorphine. Biol. Psychiatry. 26:1989;637-639.
12. Kosten T.R., Morgan C.H., Kosten T.A. Depressive symptoms during buprenorphine treatment of opioid abusers. J. Subst. Abuse Treat. 7:1990;51-54.
13. Kosten T.R., Schottenfeldr R., Ziedonis D., Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J. Nerv. Ment. Dis. 181:1993;358-364.
14. Ling W., Wesson D.R., Charavastra C., Klett J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch. Gen. Psychiatry. 53:1996;401-407.
15. Ling W., Charvuastra C., Collins J.F., Batki S. Buprenorphine maintenance treatment of opiate dependence: a multicenter randomised clinical trial. Addiction. 93:1998;475-486.
16. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P., Druley K.A. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch. Gen. Psychiatry. 40:1983;620-625.
17. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 9:1992;199-213.
18. Mello N.K., Mendelson J.H., Bree M.P., Lukas S.E. Buprenorphine suppresses cocaine self-administration by rhesus monkey. Science. 245:1989;859-862.
19. Nurnberger J.I.Jr., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training: NIMH Genetics Initiative. Arch. Gen. Psychiatry. 51:1994;849-859.
20. Nutt D., Groves S., Coupland N., Glue P. Buprenorphine in psychiatric disorders. Cowan A., Lewis J.W. Buprenorphine: Combatting Drug Abuse with a Unique Opioid. 1995;175-186 Wiley-Liss, New York.
21. Olivetto A., Feingolda A., Schottenfeld R.S., Jatlow P., Kosten T.R. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine versus methadone. Arch. Gen. Psychiatry. 56:1999;812-820.
22. Rounsaville B.J., Kosten T.R., Weissman M.M., Kleber H. Prognostic significance of psychopathology in treated opiate addicts. Arch. Gen. Psychiatry. 43:1986;739-745.
23. Schottenfed R.S., Pakes J.R., Oliveto A., Ziedonis D., Kosten T.R. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch. Gen. Psychiatry. 54:1997;713-720.
24. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid-dependence cocaine users. Psychopharmacology. 116:1994;401-406.
25. Strain E.C., Stitzer M.L., Liebsow I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid dependence: self reports urinalysis, and addiction severity index. J. Clin. Psychopharmacol. 16:1996;58-67.
26. Uelhinger L., Deglon J.J., Livoti S., Petitjean S., Waldvogel D., Ladewig D. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Eur. Addict. Res. 4:1998;13-18. (Supplement).
27. Zuckerman M., Bone R.N., Neary R., Mangelsdorff D., Brustman B. What is the sensation seeker? Personality trait and experience correlates of the sensation-seeking scales. Consult. Clin. Psychol. 39(2):1972;308-321.